DermatologyResearch Phase

Copper Peptide (Prezatide Copper Acetate)

Topical

Overview

Prezatide Copper Acetate is a tripeptide-copper complex, most commonly represented by the sequence Gly-His-Lys bound to a copper ion. Copper peptides are proposed to enhance wound healing, collagen synthesis, and angiogenesis through modulation of matrix metalloproteinases and growth factor activity.

Mechanism of Action

The copper moiety is thought to play a critical role in stabilizing the peptide and serving as a cofactor for lysyl oxidase, an enzyme essential for collagen and elastin cross-linking..

Research Summary & Key Findings

Preclinical studies in rodent wound models have demonstrated accelerated re-epithelialization and increased tensile strength. Human studies, including small trials in patients with photoaged skin and surgical wounds, have shown improvements in scar appearance and dermal thickness, though large-scale randomized controlled trials are lacking.

Clinical Status

Research Phase

Copper Peptide (Prezatide Copper Acetate) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Copper Peptide (Prezatide Copper Acetate) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Copper Peptide (Prezatide Copper Acetate).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.